Splenic arterial ligation prevents liver injury after a major hepatectomy by a reduction of surplus portal hypertension in hepatocellular carcinoma patients with cirrhosis

被引:2
|
作者
Sato, Y [1 ]
Kobayashi, T [1 ]
Nakatsuka, H [1 ]
Yamamoto, S [1 ]
Oya, H [1 ]
Watanabe, T [1 ]
Hatakeyama, K [1 ]
机构
[1] Niigata Univ, Sch Med, Dept Surg 1, Niigata 9518510, Japan
关键词
shear stress; portal hypertension; portal pressure; liver regeneration; liver injury;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: In this study, we investigated whether a reduction of surplus portal hypertension after a major hepatectomy by SPL (splenic arterial ligation) prevents a liver injury in cirrhotic patients with hepatocellular carcinoma. Methodology: Six hepatocellular carcinoma patients (SPL group) with liver cirrhosis (67 +/- 10 years old, ICGR(15): 21.0 +/-9.8%, T.Bil: 1.1 +/-1.2mg/dL) underwent major hepatectomy with splenic arterial ligation in order to reduce excessive portal hypertension after hepatectomy from 1998 to 2000, July. The patients (n=15, 60 +/-9 years old, ICGR(15): 11.5 +/-5.9%, T.Bil: 0.66 +/-0.15mg/dL) who underwent liver resection above subsegmentectomy in the same period (control group) served as the control for SPL group. Results: In the SPL group, the portal pressures before hepatectomy were 26 +/- 7cm H2O and those after hepatectomy were 29 +/- 6cm H2O. The portal pressure after splenic arterial ligation decreased to 24.5 +/-6.3cm H2O. The splenic tissue blood flows before SPL were 16.8 +/-5.6mL/min/100g, while those after SPL were 7.2 +/-2.2mL/min/100g. The portal pressures before hepatectomy were 17 +/- 2cm H2O and those after hepatectomy were 19 +/- 2cm H2O in the six control patients. At the peak levels of liver function after surgery, T.Bil was 2.6 +/-1.5mg/dL, GOT was 165 +/- 59 IU/L, and GPT was 107 +/- 49 IU/L. Ah patients could discharge without complications except for one case with bile leakage in SPL. At the peak levels of liver function in control group, T.Bil was 3.7 +/-1.9mg/dL, GOT was 404+/227 IU/L, and GPT was 322 +/- 171 IU/L. At the peak levels of Liver function after surgery, T.Bil was 3.4 +/-1.3mg/dL, GOT was 398 +/- 289 IU/L, and GPT was 319 +/- 220 IU/L. Conversely, there were 11 episodes of complications (11/15), including two cases of hospital death resulting from liver failure in patients who underwent right lobectomy, in the control patients. Conclusions: The decompression of surplus portal hypertension by SPL might be effective in the prevention of post hepatectomized Liver injury and the improvement of postoperative mortality and morbidity.
引用
收藏
页码:831 / 835
页数:5
相关论文
共 45 条
  • [1] The subcutaneous splenic transposition prevents liver injury induced by excessive portal pressure after massive hepatectomy
    Koyama, S
    Sato, Y
    Hatakeyama, K
    HEPATO-GASTROENTEROLOGY, 2003, 50 (49) : 37 - 42
  • [2] Transcatheter arterial chemoembolization for hepatocellular carcinoma in cirrhosis: influence on portal hypertension
    Elia, Chiara
    Venon, Wilma Debernardi
    Stradella, Davide
    Martini, Silvia
    Brunello, Franco
    Marzano, Alfredo
    Saracco, Giorgio
    Rizzetto, Mario
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 23 (07) : 573 - 577
  • [3] Outcome of Hepatectomy for Hepatocellular Carcinoma in Elderly Patients With Portal Hypertension
    Mori, Shozo
    Kita, Junji
    Shimizu, Takayuki
    Kato, Masato
    Shimoda, Mitsugi
    Kubota, Keiichi
    INTERNATIONAL SURGERY, 2014, 99 (02) : 153 - 160
  • [4] Synchronous Spienectomy and Hepatectomy in Patients with Hepatocellular Carcinoma, Hypersplemism and Liver Cirrhosis
    Shi, Rui
    Zhang, Ya-Min
    Zhu, Zhi-Jun
    Deng, Yong-Lin
    Pan, Cheng
    Zheng, Hong
    Shen, Zhong-Yang
    HEPATO-GASTROENTEROLOGY, 2014, 61 (133) : 1363 - 1367
  • [5] Application of associating liver partition and portal vein ligation for staged hepatectomy for initially unresectable hepatocellular carcinoma
    Haoqi Chen
    Xiaowen Wang
    Wenfeng Zhu
    Yang Li
    Zhenyu Yu
    Hua Li
    Yang Yang
    Shuguang Zhu
    Xiaolong Chen
    Genshu Wang
    BMC Surgery, 22
  • [6] DIAGNOSIS OF CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN PATIENTS WITH CIRRHOSIS: SPLENIC ARTERIAL RESISTIVE INDEX VERSUS LIVER STIFFNESS MEASUREMENT
    Lee, Chul-Min
    Jeong, Woo Kyoung
    Lim, Sanghyeok
    Kim, Yongsoo
    Kim, Jinoo
    Kim, Tae Yeob
    Sohn, Joo Hyun
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2016, 42 (06) : 1312 - 1320
  • [7] Impact of liver volumetric regeneration on survival outcomes in patients with hepatocellular carcinoma after major hepatectomy
    Nguyen Hai Nam
    Tomoaki Yoh
    Yutaro Hori
    Koshiro Morino
    Hiroto Nishino
    Takahiro Nishio
    Yukinori Koyama
    Satoshi Ogiso
    Kazuyuki Nagai
    Ken Fukumitsu
    Yoichiro Uchida
    Takashi Ito
    Takamichi Ishii
    Satoru Seo
    Koichiro Hata
    Kojiro Taura
    Etsuro Hatano
    Langenbeck's Archives of Surgery, 408
  • [8] Application of associating liver partition and portal vein ligation for staged hepatectomy for initially unresectable hepatocellular carcinoma
    Chen, Haoqi
    Wang, Xiaowen
    Zhu, Wenfeng
    Li, Yang
    Yu, Zhenyu
    Li, Hua
    Yang, Yang
    Zhu, Shuguang
    Chen, Xiaolong
    Wang, Genshu
    BMC SURGERY, 2022, 22 (01)
  • [9] Impact of liver volumetric regeneration on survival outcomes in patients with hepatocellular carcinoma after major hepatectomy
    Nam, Nguyen Hai
    Yoh, Tomoaki
    Hori, Yutaro
    Morino, Koshiro
    Nishino, Hiroto
    Nishio, Takahiro
    Koyama, Yukinori
    Ogiso, Satoshi
    Nagai, Kazuyuki
    Fukumitsu, Ken
    Uchida, Yoichiro
    Ito, Takashi
    Ishii, Takamichi
    Seo, Satoru
    Hata, Koichiro
    Taura, Kojiro
    Hatano, Etsuro
    LANGENBECKS ARCHIVES OF SURGERY, 2023, 408 (01)
  • [10] A novel surgical scheme for hepatectomy in hepatocellular carcinoma patients with clinically significant portal hypertension
    Ye, Jia-zhou
    Lu, Hua-ze
    Zeng, Can
    Lei, Guo
    Wang, Xiao-bo
    Chen, Jie
    Bai, Tao
    Wu, Fei-xiang
    Mai, Rong-yun
    Guo, Wei-xing
    Li, Le-qun
    BMC CANCER, 2024, 24 (01)